Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 14 Multiple Myeloma 6 Lung Neoplasms 6 Lymphoma 5 Lymphoma, Large-Cell, Anaplastic 3 Hematologic Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Adenocarcinoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma, Alveolar 1 Relapsed Pediatric Solid Tumor 1 Rectal Neoplasms 1 Rare Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1

Interventions

Cyclophosphamide 155 Rituximab 148 Etoposide 84 fludarabine phosphate 73 Peripheral Blood Stem Cell Transplantation 68 Mycophenolic Acid 63 Busulfan 62 Filgrastim 59 Melphalan 58 Tacrolimus 54 Whole-Body Irradiation 51 Cytarabine 46 fludarabine 45 Radiotherapy 43 Methotrexate 41 Granulocyte Colony-Stimulating Factor 41 Cyclosporine 41 Vincristine 35 Antilymphocyte Serum 35 Carmustine 33 Doxorubicin 29 Prednisone 26 Thiotepa 25 Bendamustine Hydrochloride 24 Methylprednisolone 22 Ifosfamide 22 Dexamethasone 22 thymoglobulin 21 sargramostim 20 plerixafor 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Non-Hodgkin × Crizotinib × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡